Research into weight-loss drugs tipped for Nobel as award week opens
Research into hormones that regulate appetite is on everybody's lips for the Nobel medicine prize, to be announced on Monday when the 2026 Nobel season kicks off.
The Nobel Medicine Prize, set to be announced on Monday during the 2026 Nobel season, may go to research on hormones that regulate appetite, which could include the discovery of leptin and ghrelin, as well as research on GLP-1, a hormone released by the intestine after eating that signals satiety. Drugs like Ozempic mimic this hormone and have had a significant worldwide clinical impact, making it a top contender for the prize.
Other potential winners include stem cell research for skin regeneration, a new imaging technique called optical coherence tomography, and research on adhesion receptors in the immune system. The Nobel Prize for literature is expected to be announced on Thursday, with some suggesting a possible award for a woman writer, possibly from Latin America.
The Nobel Peace Prize will be awarded in Oslo on Friday, with speculation centered around a figure who enjoys broad consensus. The Economics Prize for 2026 will be revealed on October 12.
Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
